America’s Patent for CBD’s

The Truth About the US Government’s CBD Patent

Though we have come a long way with almost half of the United States already legalizing medicinal marijuana, there are still obstacles to hurdle when looking more thoroughly into the medical marijuana industry.For starters marijuana is still very much illegal on a federal level, although certain  states that allow medicinal or recreational use with a doctors recommendation. People raise concerns about the influential impact this industry will have  on the future of America.the national institute (NIH) obtained a patent in 2003, US PATENT 6630507,  and titled cannabinoids as antioxidants and nueroprotectents . Although this shows that the NIH is doing their job and researching CBDs, it has been argued that due to federal illegality and the fact that if a composition occurs in nature it can’t be patented, according to the supreme court,  unless it can be proven that it has been changed.  Its been stated by theSupreme court that patents can only be issued if it can be proven to have been changed or manipulated by the hand of man. Without a knowledge or data to prove natural composition, the basis for a patent cannot be proven.

With legalization of cannabis proper research can be done to establish a databank of genetic composition that occurs naturally and proof of manipulation or change can be proven and lead to better medicines and treatments.The testing and CBD patent proves they acknowledged the benefits and are researching for future progression with CBDS.Medical Marijuana Inc. (MJNA), is a publicly traded marijuana stock.Along with their subsidiaries, KannaLife Science and Kannaway, they are determined to continue making breakthroughs and discoveries with CBD’s to help  patients who suffer from various diseases seeking proper medical treatment to alleviate their symptoms.